These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3292871)

  • 1. The effects of intravenous prostacyclin in a model of microsurgical thrombosis.
    Bailes JE; Quigley MR; Kwaan HC; Nishiura BR; Cerullo LJ; Lastre C
    Microsurgery; 1988; 9(1):2-9. PubMed ID: 3292871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous infusion of prostacyclin to prevent platelet thrombus during microvascular anastomoses.
    Gateley DR; McAnulty GR; Martin DL
    Br J Plast Surg; 1996 Jun; 49(4):249-50. PubMed ID: 8757677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
    Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of prostacyclin in preventing occlusion of microvascular anastomoses by platelet thrombus: an experimental study in rats.
    Emerson DJ; Patel CB; Krishna BV; Sykes PJ
    Br J Plast Surg; 1981 Jan; 34(1):35-7. PubMed ID: 7006721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
    Ching S; Thoma A; Monkman S; Kelton JG
    Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
    Mogielnicki A; Kramkowski K; Pietrzak L; Buczko W
    J Physiol Pharmacol; 2007 Sep; 58(3):515-27. PubMed ID: 17928647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal laser arterial injury and prostacyclin administration in dogs: thrombotic and hyperplastic consequences.
    Hehrlein C; Svenson RH; McKusik AP; Chuang CH; Tuntelder JR; Tatsis GP; Littmann L; Thompson M
    J Cardiovasc Surg (Torino); 1992; 33(3):366-71. PubMed ID: 1601923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
    Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
    Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous infusion of prostacyclin (PGI2) in man.
    O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
    Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of JLX001 on cerebral ischemia through inhibiting platelet activation and thrombus formation in rats.
    Yan YY; Ao LY; Zhou L; Li CY; Fang WR; Shen WY; Liang BW; Zhu X; Li YM
    Biomed Pharmacother; 2018 Oct; 106():805-812. PubMed ID: 29990874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
    Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
    J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
    Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
    Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue.
    Hirasawa Y; Nishio M; Maeda K; Yoshida K; Kita Y
    Eur J Pharmacol; 1995 Jan; 272(1):39-43. PubMed ID: 7713147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
    Katsube N; Sakaguchi K; Fujitani B; Aishita H
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin and risk of thromboembolism.
    Varela-Aguilar JM; Sánchez-Hueso MC; González-Jimenez MD; García-Contreras RF; González dela Puente MA
    Eur Heart J; 1997 Feb; 18(2):349. PubMed ID: 9043854
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U-46619-induced ischaemic electrocardiographic changes in rats: preventive effects of prostacyclin and nitroglycerin.
    Yamamoto T; Kikuta C; Hosoki K
    J Pharm Pharmacol; 1994 Jul; 46(7):558-62. PubMed ID: 7996382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on preventive effects of API0134 on vessel reocclusion after thrombolysis.
    Xiong YL; Zhao HY
    J Tongji Med Univ; 1995; 15(2):77-81. PubMed ID: 8731957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and antithrombotic effects of ZK 96 480, a novel metabolically stable carbacyclin derivative with oral activity.
    Stürzebecher CS; Loge O; Schröder G; Müller B; Witt W
    Prog Clin Biol Res; 1987; 242():425-31. PubMed ID: 3313417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.